October 15, 2025Baylor Genetics Presents New Data on Clinical and Diagnostic Utility of RNA Sequencing for Rare Disease at the American Society of Human Genetics 2025 Annual MeetingRead More
October 8, 2025Baylor Genetics to Showcase Clinical and Diagnostic Utility of Genome Sequencing and Multi-omics Across Rare Disease at the American Society of Human Genetics 2025 Annual MeetingRead More
September 22, 2025Baylor Genetics to Showcase the Expanding Role and Clinical Value of Genetic Testing in Pediatric Neurology at the 2025 Child Neurology Society Annual MeetingRead More
September 18, 2025Baylor Genetics’ Chief Medical Officer Dr. Christine Eng Named Woman Scientist of the Year in 2025 Stevie® Awards for Women in BusinessRead More
August 25, 2025Baylor Genetics to Showcase RNA Sequencing Breakthroughs for Rare Disease Diagnosis at 2025 AGBT Precision Health MeetingRead More
August 18, 2025Baylor Genetics Highlights the Ongoing Utility of Chromosome Analysis in Plasma Cell Disorders at the 16th Annual Cancer Genomics Consortium MeetingRead More
August 14, 2025Baylor Genetics Hosts Webinar Highlighting the Power of Whole Genome Sequencing in Complex Pediatric CasesRead More
July 25, 2025Baylor Genetics to Present on Role of Whole Genome Sequencing in Diagnosing ReNU Syndrome at Inaugural ReNU Hope Scientific SymposiumRead More
June 30, 2025Baylor Genetics’ Chairman and CEO Kengo Takishima Named One of Houston Business Journal’s 2025 Most Admired CEOsRead More
June 26, 2025Baylor Genetics Supports AAP’s New Guidance on Genomic Testing for Developmental DelaysRead More
April 28, 2025Baylor Genetics Joins Child Neurology Society as Official Genetic Testing PartnerRead More
March 21, 2025Baylor Genetics Presents New Data on Genetic and Functional Testing to Diagnose Mitochondrial Disorders at 2025 ACMG Annual Clinical Genetics MeetingRead More
March 11, 2025Baylor Genetics to Showcase Genetic Testing Innovations for Rare Disease at ACMG 2025 Annual Clinical Genetics MeetingRead More
February 11, 2025Baylor Genetics Marks a Decade of Leadership in Precision Diagnostics, Empowering Patients, Healthcare Providers and Partners with Trusted Genetic InsightsRead More
February 4, 2025Baylor Genetics Chief Medical Officer Christine Eng, M.D., Shares New RNA Sequencing Insights for Rare Disease at Precision Medicine World Conference 2025Read More
January 13, 2025Baylor Genetics to Integrate with Epic Aura to Enhance Efficiency and Deliver Genetic Testing Results to Hospitals and Health SystemsRead More
October 3, 2024Baylor Genetics to Present Research Findings Aimed to Improve Patient Care at Upcoming ICoNS, NORD, and ASHG ConferencesRead More
September 10, 2024Baylor Genetics Named to Fast Company’s Best Workplaces for Innovators ListRead More
September 9, 2024Baylor Genetics’ Presentations at the National Society for Genetic Counselors’ 2024 Annual Meeting Highlight How Genetic Testing Can End the Diagnostic OdysseyRead More
August 5, 2024Baylor Genetics and Baylor College of Medicine Announce New Lab Agreement with Shared Commitment to Innovation and Rapid Implementation to get Critical Testing to PatientsRead More
May 13, 2024Baylor Genetics Launches RNASeq Test for Whole Genome and Whole Exome Sequencing, Reduces Turnaround Times, Introduces Four New Genetic Analysis PanelsRead More
April 16, 2024Baylor Genetics Prepares for a ‘Genome World’ With Explainable AI-Powered Variant InterpretationRead More
March 4, 2024Baylor Genetics to Share Scientific and Clinical Insights on AI, Precision Diagnostics, Carrier Screening and More in 11 Presentations at ACMG 2024Read More
January 23, 2024Baylor Genetics Chief Medical Officer Christine Eng, MD, Shares Sequencing Approaches for Undiagnosed Patients at Precision Medicine World Conference 2024Read More
January 3, 2024Baylor Genetics Accelerates Growth, Combines Clinical and Scientific Expertise with Commercial Capabilities to Meet Increased Needs of Patients, Providers and PartnersRead More
October 2, 2023Baylor Genetics to Present Scientific Research Findings at Upcoming NORD, NSGC, and ASHG ConferencesRead More
September 12, 2023Baylor Genetics Announces Neurodevelopmental Disorders Test Panel to Help Healthcare Providers Diagnose Patients with Intellectual Disabilities or Developmental DelaysRead More
December 28, 2021Baylor Genetics and SRL, Inc. Initiate Clinical Grade of Exome and Genome Sequencing Technology TransferRead More
November 17, 2020Baylor Genetics Launches Combination Test for COVID-19 and Influenza A and BRead More
August 12, 2020Baylor Genetics and Rice University Form COVID-19 Screening Partnership for the Fall SemesterRead More
October 22, 2019Baylor Genetics, Miraca Research Institute Explore EV Purification for Cancer-Based ApplicationsRead More
May 10, 2019Baylor Genetics and King Faisal Specialist Hospital – Saudi Diagnostic Limited Sign Memorandum of Understanding (MOU)Read More
March 27, 2019Baylor College of Medicine’s Department of Molecular and Human Genetics Named No. 1 in the U.S.Read More
March 6, 2018Baylor Genetics expands its precision medicine portfolio with ClariFind, a somatic tumor test using next-generation sequencing to match genomic results with personalized treatment options.Read More
November 9, 2017Genetic Counselors Can Help You Navigate The Murky Waters Of Genetic TestingRead More
November 8, 2017UnitedHealthcare’s Genetic & Molecular Lab Testing Notification / Prior Authorization ProgramRead More
September 24, 2017Baylor Genetics Partners with Rainbow Genomics Offering Adult Wellness Screening and High-Risk Cancer Exome Sequencing Tests in Asian PacificRead More
August 17, 2017Fluidigm Licenses CFTR Next-Generation Sequencing Assay From Baylor Genetics for Use With the Juno SystemRead More
April 23, 2016Shashikant Kulkarni joins as senior Vice President of Lab Operations, Chief Science OfficerRead More
November 17, 2015Baylor Genetics Incorporates Oxford Gene Technology’s SNP Array Probe TechnologyRead More
May 14, 2015Critical WES Launches Enhanced Clinical Exome Sequencing Test, Faster Delivery of ResultsRead More
